9.1 Infectious diseases
Fever
Fever is one of the most common presenting complaints in children in both the primary care and emergency department settings. Of all children’s visits to the emergency department (ED), 20–30% are with acute episodes of fever.1 In children <1 year old presenting to EDs in Australia and New Zealand, fever without identifiable source is the diagnosis in over 3%.2 In the first 2 years of life, children average four to six febrile episodes. Those in child care may have many more than this.
Defining and measuring temperature
There is controversy regarding the most appropriate thermometer and the best anatomical site for temperature measurement.3 Parents often use touch to detect fever in their children. However, touch has only 50% specificity.4 It tends to overestimate the incidence of fever, and is more useful to exclude fever. Rectal temperature has long been considered the gold standard for routine measurement of body temperature, but it does not in fact reflect true core temperature within the pulmonary artery. Moreover, parents and patients generally prefer other temperature assessments. Nonetheless, rectal temperature remains the most widely used measure in infants under 3 months of age. Tympanic thermometers provide the most accurate assessment of core temperature, but the probe may be too large for an infant’s auditory canal. Oral temperature requires patient cooperation, and is generally unsuitable for children under the age of 5 years. Axillary temperature measurement is inaccurate and insensitive.
Fever: to treat or not to treat?
The drugs most commonly used for treating fever are paracetamol, ibuprofen and aspirin. The routine use of these medications in the treatment of fever has been questioned.5 In particular, there has been concern that the use of antipyretics may prolong viral shedding, impair antibody response to viral infection, and may increase morbidity and mortality.5–7 Moreover, each of the commonly used antipyretics may have significant adverse effects such as hepatic dysfunction, metabolic acidosis, Reye syndrome and gastrointestinal bleeding. Treatment should therefore be focused on alleviation of discomfort or pain rather than on the height of the temperature. Either paracetamol or ibuprofen may be used. It is important to note that the use of antipyretics has not been shown to prevent febrile convulsions.
Paracetamol may be given orally, rectally or intravenously at a dose of 10–15 mg kg−1 4–6-hourly. In an unsupervised, community setting, the total daily dose should be limited to 60 mg kg−1, although up to 90 mg kg−1 per 24 hrs can be used under medical supervision. Single doses of 30 mg kg−1 may be used for night-time dosing. Serious toxicity has been reported in children with chronic daily over-dosage, mostly occurring in children who have a febrile illness and associated anorexia, vomiting and/or dehydration.8 A child should be reviewed after 48 hours if regular paracetamol has been ‘required’ for this period.
Ibuprofen can be used as an alternative to paracetamol at a dose of 5–10 mg kg−1 (maximum of 500 mg per dose), given 6- to 8-hourly (maximum daily dose of 40 mg kg−1 or 2 g). It is recommended that it be used alone, and not in combination with paracetamol, as this practice may lead to an increase in adverse effects, including gastrointestinal bleeding, renal dysfunction and anaphylaxis.7 A theoretical risk of aggravating concurrent asthma has also been described, although these adverse effects are refuted in large prospective studies.8 There is also a concern that ibuprofen may be associated with an increased risk of necrotising group A streptococcal infections.9 There is no evidence that alternating paracetamol and ibuprofen is any better at reducing fever or spares the potential hepatotoxicity related to paracetamol administration.9
Fever without focus
Occult bacteraemia is the presence of bacteria in the bloodstream of a febrile child who has no apparent focus of infection and looks well. Diagnosis is by blood culture and exclusion of focal infection. The incidence of occult bacteraemia in febrile children has reduced dramatically to <1% since the introduction of conjugate pneumococcal vaccine.10,11
It is difficult to assess whether a child is ‘septic’ or ‘toxic’. A simple and effective approach that is useful in the ED is a combination of ABC, fluids-in and fluids-out.12 An infant with one or more of these symptoms or signs has a higher risk of serious illness:
When considering management strategies for febrile infants, three age groups are generally assigned: <1 month of age, 1–3 months and >3 months (Table 9.1.1). Infants less than 1 month of age, and those with any of the risk factors above require several investigations including full blood examination, culture of blood, urine and cerebrospinal fluid (CSF), and a chest X-ray if indicated. Empiric antimicrobial therapy should be based on the patient’s clinical illness, risk factors, and the local epidemiology of potential pathogens and their antibiotic susceptibility.
Empiric IV antibiotics: amoxicillin and cefotaxime
± blood and CSF cultures ± CXR
Discharge with arranged review
CXR, chest X-ray; FBE, full blood examination; CSF, cerebrospinal fluid.
Clinical scores, such as the Rochester and Boston criteria, have been devised to identify children at low risk of serious bacterial infection.13 However, their utility has been questioned in the era of widespread Hib and conjugate pneumococcal vaccination.
As urinary tract infection is the most common serious bacterial infection among febrile infants and children, urine microscopy and culture should be included in the investigation of most such children. In infants, a urine sample should ideally be obtained via suprapubic aspiration or catheter. A negative urinalysis does not exclude a urinary tract infection, which may occur in the absence of pyuria.14,15
Pyrexia of unknown origin (PUO)
Kawasaki disease is an important consideration in an infant or child presenting with prolonged fever, and diagnosis is often delayed. There is a degree of urgency in diagnosis, because treatment within 10 days of onset of fever with intravenous immunoglobulin and aspirin reduces the incidence of coronary artery lesions from around 20% to around 5%.16